M. Ahmad, T. Takino, H. Miyamori, T. Yoshizaki, M. Furukawa et al., Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide, J. Biochem. Z. A. J. Neurosci, vol.139, issue.16, pp.517-5261, 1996.

V. Buggia-prevot, J. Sevalle, S. Rossner, and F. Checler, NFkappaBdependent control of BACE1 promoter transactivation by Abeta42, J. Biol, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00315597

. Chemjbc, E. Candelario-jalil, Y. Yang, and G. A. Rosenberg, Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia, Neuroscience, vol.283, issue.158, pp.10037-10047, 2009.

F. A. Chaillan, S. Rivera, E. Marchetti, J. Jourquin, Z. Werb et al., Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice, Behavioural Brain Research, vol.173, issue.2, pp.191-198, 2006.
DOI : 10.1016/j.bbr.2006.06.020

URL : https://hal.archives-ouvertes.fr/inserm-00092843

L. Chami and F. Checler, BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and ??-amyloid production in Alzheimer???s disease, Molecular Neurodegeneration, vol.7, issue.1, pp.52-62, 2012.
DOI : 10.1186/1750-1326-7-52

N. Chevallier, J. Jiracek, B. Vincent, C. P. Baur, M. G. Spillantini et al., secretion by human transfected cells, British Journal of Pharmacology, vol.78, issue.Suppl. 139, pp.556-562, 1997.
DOI : 10.1074/jbc.271.32.19606

J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski et al., Natural oligomers of the amyloid-?? protein specifically disrupt cognitive function, Nature Neuroscience, vol.94, issue.1, pp.79-84, 2005.
DOI : 10.1073/pnas.94.4.1550

I. Dafnis, A. K. Tzinia, E. C. Tsilibary, V. I. Zannis, and A. Chroni, An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines, Neuroscience, vol.210, 2012.
DOI : 10.1016/j.neuroscience.2012.03.013

S. Deb, W. Zhang, J. Gottschall, and P. E. , Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes, 2003.

D. Strooper and B. , Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process, Physiological Reviews, vol.5, issue.2, pp.465-494, 2009.
DOI : 10.1523/JNEUROSCI.1549-07.2007

M. Fanjul-fernández, A. R. Folgueras, S. Cabrera, and C. López-otín, Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1803, issue.1, 2010.
DOI : 10.1016/j.bbamcr.2009.07.004

P. Giannoni, F. Gaven, D. De-bundel, K. Baranger, E. Marchetti-gauthier et al., Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer???s disease, Frontiers in Aging Neuroscience, vol.5, 2013.
DOI : 10.3389/fnagi.2013.00096

URL : https://hal.archives-ouvertes.fr/hal-01703910

S. D. Girard, K. Baranger, C. Gauthier, M. Jacquet, A. Bernard et al., Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.333233, pp.781-796, 2012.

S. D. Girard, M. Jacquet, K. Baranger, M. Migliorati, G. Escoffier et al., Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.29, issue.7, pp.762-772, 2014.
DOI : 10.1016/j.neurobiolaging.2006.12.004

B. Gonthier, C. Nasarre, L. Roth, M. Perraut, N. Thomasset et al., Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance Alzheimer's disease: the amyloid cascade hypothesis, Cereb. Cortex Science, vol.17, issue.256, pp.184-185, 1992.
DOI : 10.1016/j.ijdevneu.2006.09.308

URL : http://cercor.oxfordjournals.org/content/17/7/1712.full.pdf

J. Hu, P. E. Van-den-steen, Q. X. Sang, and G. Opdenakker, Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases, Nature Reviews Drug Discovery, vol.282, issue.6, pp.480-498, 1038.
DOI : 10.4049/jimmunol.168.9.4361

S. Jawhar, A. Trawicka, C. Jenneckens, T. A. Bayer, and O. Wirths, Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A?? aggregation in the 5XFAD mouse model of Alzheimer's disease, Neurobiology of Aging, vol.33, issue.1, pp.29-196, 2012.
DOI : 10.1016/j.neurobiolaging.2010.05.027

J. Jourquin, E. Tremblay, A. Bernard, G. Charton, F. A. Chaillan et al., Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory, European Journal of Neuroscience, vol.18, issue.10, pp.2569-2578, 2005.
DOI : 10.1016/j.neuroscience.2004.09.064

URL : https://hal.archives-ouvertes.fr/hal-00095130

J. Jourquin, E. Tremblay, N. Décanis, G. Charton, S. Hanessian et al., Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate, European Journal of Neuroscience, vol.19, issue.6, pp.1507-1517, 2003.
DOI : 10.1046/j.1460-9568.1998.00347.x

S. S. Jung, W. Zhang, W. E. Van-nostrand, A. Kaliszewska, M. Bijata et al., Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells Experiencedependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, pp.1208-1215, 2003.

A. Langenfurth, J. L. Rinnenthal, K. Vinnakota, V. Prinz, A. S. Carlo et al., Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases, Journal of Neuroscience Research, vol.90, issue.8, pp.275-286, 2013.
DOI : 10.1007/BF00294800

I. Lauritzen, R. Pardossi-piquard, C. Bauer, E. Brigham, J. D. Abraham et al., The ??-Secretase-Derived C-Terminal Fragment of ??APP, C99, But Not A??, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus, Journal of Neuroscience, vol.32, issue.46, pp.16243-16255, 2012.
DOI : 10.1523/JNEUROSCI.2775-12.2012

R. N. Lepage, A. J. Fosang, S. J. Fuller, G. Murphy, G. Evin et al., Gelatinase A possesses a ??-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease, FEBS Letters, vol.210, issue.2, pp.267-270, 1995.
DOI : 10.1006/excr.1994.1036

S. Lesné, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe et al., A specific amyloid-?? protein assembly in the brain impairs memory, Nature, vol.81, issue.7082, pp.352-357, 1038.
DOI : 10.1046/j.1471-4159.2002.00901.x

M. Mazzone, M. Baldassarre, G. Beznoussenko, G. Giacchetti, J. Cao et al., Intracellular processing and activation of membrane type 1 matrix metalloprotease depends on its partitioning into lipid domains, Journal of Cell Science, vol.117, issue.26, pp.6275-6287, 2004.
DOI : 10.1242/jcs.01563

S. E. Meighan, P. C. Meighan, P. Choudhury, C. J. Davis, M. L. Olson et al., Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity, Journal of Neurochemistry, vol.10, issue.5, pp.1227-1241, 2006.
DOI : 10.1046/j.1460-9568.1998.00347.x

H. Mizoguchi, K. Takuma, E. Fukuzaki, D. Ibi, E. Someya et al., Matrix Metalloprotease-9 Inhibition Improves Amyloid ??-Mediated Cognitive Impairment and Neurotoxicity in Mice, Journal of Pharmacology and Experimental Therapeutics, vol.331, issue.1, pp.14-22, 2009.
DOI : 10.1124/jpet.109.154724

URL : http://jpet.aspetjournals.org/content/jpet/331/1/14.full.pdf

M. Moon, H. S. Hong, D. W. Nam, S. H. Baik, H. Song et al., Intracellular amyloid-beta accumulation in calcium-binding protein-deficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer's disease, J. Alzheimers Dis, vol.293233, pp.615-628, 2011.

V. Nagy, O. Bozdagi, A. Matynia, M. Balcerzyk, P. Okulski et al., Matrix Metalloproteinase-9 Is Required for Hippocampal Late-Phase Long-Term Potentiation and Memory, Journal of Neuroscience, vol.26, issue.7, pp.1923-1934, 2006.
DOI : 10.1523/JNEUROSCI.4359-05.2006

URL : http://www.jneurosci.org/content/jneuro/26/7/1923.full.pdf

H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao et al., Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation, Journal of Neuroscience, vol.26, issue.40, pp.10129-10140, 2006.
DOI : 10.1523/JNEUROSCI.1202-06.2006

C. Bernard, A. Chollet, A. M. , L. E. Diguardher, T. Hanessian et al., Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins, Frontiers in Aging Neuroscience www.frontiersin.org Ogier, pp.272-284, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00092816

C. Ogier, R. Creidy, J. Boucraut, P. D. Soloway, M. Khrestchatisky et al., Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study, BMC Neuroscience, vol.6, issue.1, pp.68-78, 2005.
DOI : 10.1186/1471-2202-6-68

URL : https://hal.archives-ouvertes.fr/hal-00092828

A. Ould-yahoui, E. Tremblay, O. Sbai, L. Ferhat, A. Bernard et al., A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons, PLoS ONE, vol.4, issue.12, 2009.
DOI : 10.1371/journal.pone.0008289.s004

S. Rivera, M. Khrestchatisky, L. Kaczmarek, G. A. Rosenberg, and D. M. Jaworski, Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?, Journal of Neuroscience, vol.30, issue.46, pp.15337-15357, 2010.
DOI : 10.1523/JNEUROSCI.3467-10.2010

URL : http://www.jneurosci.org/content/jneuro/30/46/15337.full.pdf

S. Rivera, C. Ogier, J. Jourquin, S. Timsit, A. Szklarczyk et al., Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, European Journal of Neuroscience, vol.10, issue.1, pp.19-32, 1997.
DOI : 10.1046/j.1460-9568.1998.00347.x

A. E. Roher, T. C. Kasunic, A. S. Woods, R. J. Cotter, M. J. Ball et al., Proteolysis of A?? Peptide from Alzheimer Disease Brain by Gelatinase A, Biochemical and Biophysical Research Communications, vol.205, issue.3, pp.1755-1761, 1994.
DOI : 10.1006/bbrc.1994.2872

O. Sbai, L. Ferhat, A. Bernard, Y. Gueye, A. Ould-yahoui et al., Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells, Molecular and Cellular Neuroscience, vol.39, issue.4, pp.549-568, 2008.
DOI : 10.1016/j.mcn.2008.08.004

URL : https://hal.archives-ouvertes.fr/hal-00321014

O. Sbai, A. Ould-yahoui, L. Ferhat, Y. Gueye, A. Bernard et al., Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes, Glia, vol.924, issue.1/2, pp.344-366, 2010.
DOI : 10.1016/0304-4165(87)90091-2

G. M. Shankar, S. Li, T. H. Mehta, A. Garcia-munoz, N. E. Shepardson et al., Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation, Nat. Med. J. Biol. Chem, vol.14, issue.269, pp.837-842, 1994.

A. Y. Strongin, I. Collier, G. Bannikov, B. L. Marmer, G. A. Grant et al., Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase, Journal of Biological Chemistry, vol.142, issue.10, pp.5331-5338, 1995.
DOI : 10.1002/ijc.2910580102

A. A. Talamagas, S. Efthimiopoulos, E. C. Tsilibary, M. E. Figueiredo-pereira, and A. K. Tzinia, Abeta(1???40)-induced secretion of matrix metalloproteinase-9 results in sAPP?? release by association with cell surface APP, Neurobiology of Disease, vol.28, issue.3, pp.304-315, 2007.
DOI : 10.1016/j.nbd.2007.07.016

M. Townsend, G. M. Shankar, T. Mehta, D. M. Walsh, and D. J. Selkoe, Effects of secreted oligomers of amyloid ??-protein on hippocampal synaptic plasticity: a potent role for trimers, The Journal of Physiology, vol.64, issue.2, pp.477-492, 2005.
DOI : 10.1146/annurev.physiol.64.092501.114547

D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl et al., Naturally secreted oligomers of amyloid ?? protein potently inhibit hippocampal long-term potentiation in vivo, Nature, vol.36, issue.6880, pp.535-539, 1038.
DOI : 10.1021/jm00054a014

Y. Yang, E. Y. Estrada, J. F. Thompson, W. Liu, and G. A. Rosenberg, Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat, Journal of Cerebral Blood Flow & Metabolism, vol.112, issue.4, pp.697-709, 2007.
DOI : 10.1016/j.nbd.2004.08.001

K. Yin, J. R. Cirrito, P. Yan, X. Hu, Q. Xiao et al., Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-beta Peptide Catabolism, Journal of Neuroscience, vol.26, issue.43, pp.10939-10948, 2006.
DOI : 10.1523/JNEUROSCI.2085-06.2006

URL : http://www.jneurosci.org/content/jneuro/26/43/10939.full.pdf